Tower Research Capital (TRC)’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-1,679
| Closed | -$6K | – | 4695 |
|
2019
Q1 | $6K | Sell |
1,679
-2,157
| -56% | -$7.71K | ﹤0.01% | 3022 |
|
2018
Q4 | $24K | Buy |
3,836
+3,076
| +405% | +$19.2K | ﹤0.01% | 1811 |
|
2018
Q3 | $4K | Sell |
760
-504
| -40% | -$2.65K | ﹤0.01% | 3261 |
|
2018
Q2 | $5K | Sell |
1,264
-10,517
| -89% | -$41.6K | ﹤0.01% | 3100 |
|
2018
Q1 | $52K | Buy |
+11,781
| New | +$52K | ﹤0.01% | 1659 |
|
2017
Q4 | – | Sell |
-8,524
| Closed | -$52K | – | 4448 |
|
2017
Q3 | $52K | Buy |
+8,524
| New | +$52K | ﹤0.01% | 1940 |
|
2017
Q2 | – | Sell |
-1,971
| Closed | -$10K | – | 3982 |
|
2017
Q1 | $10K | Sell |
1,971
-2,627
| -57% | -$13.3K | ﹤0.01% | 1809 |
|
2016
Q4 | $33K | Buy |
+4,598
| New | +$33K | ﹤0.01% | 1723 |
|
2016
Q3 | – | Sell |
-100
| Closed | -$1K | – | 4927 |
|
2016
Q2 | $1K | Sell |
100
-1,129
| -92% | -$11.3K | ﹤0.01% | 4290 |
|
2016
Q1 | $7K | Sell |
1,229
-92
| -7% | -$524 | ﹤0.01% | 2454 |
|
2015
Q4 | $7K | Buy |
+1,321
| New | +$7K | ﹤0.01% | 2665 |
|
2015
Q2 | – | Sell |
-1,246
| Closed | -$20K | – | 5384 |
|
2015
Q1 | $20K | Buy |
+1,246
| New | +$20K | ﹤0.01% | 2266 |
|
2014
Q4 | – | Sell |
-706
| Closed | -$7K | – | 5058 |
|
2014
Q3 | $7K | Buy |
706
+595
| +536% | +$5.9K | ﹤0.01% | 3104 |
|
2014
Q2 | $2K | Sell |
111
-2,075
| -95% | -$37.4K | ﹤0.01% | 3520 |
|
2014
Q1 | $41K | Buy |
+2,186
| New | +$41K | 0.01% | 1248 |
|
2013
Q3 | – | Sell |
-10
| Closed | – | – | 5007 |
|
2013
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4010 |
|